Fenwick & West LLP advised Sutro Biopharma on the deal. Sutro Biopharma (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
